+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Hypertrophic & Keloid Scar Treatment Market by Scar Type (Hypertrophic Scar, Keloid Scar), Product (Injectables, Laser Products, Topical Products), End-Use - Forecast 2024-2030

  • PDF Icon

    Report

  • 182 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5613237
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Hypertrophic & Keloid Scar Treatment Market size was estimated at USD 1.67 billion in 2023, USD 1.91 billion in 2024, and is expected to grow at a CAGR of 14.33% to reach USD 4.28 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Hypertrophic & Keloid Scar Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Hypertrophic & Keloid Scar Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Hypertrophic & Keloid Scar Treatment Market, highlighting leading vendors and their innovative profiles. These include Alliance Pharma, PLC, Cynosure, Inc., Honeydew Products, L'Oreal Group, Lumenis Be Ltd., McKesson Medical-Surgical Inc., Merz Pharma, Molnlycke Health Care AB, Newmedical Technology, Inc., Pacific World Corporation, Perrigo Company PLC, Smith & Nephew PLC, Sonoma Pharmaceuticals, Inc., and Suneva Medical, Inc.

Market Segmentation & Coverage

This research report categorizes the Hypertrophic & Keloid Scar Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Scar Type
    • Hypertrophic Scar
    • Keloid Scar
  • Product
    • Injectables
    • Laser Products
    • Topical Products
  • End-Use
    • Clinics
    • Hospitals
    • Retail Pharmacies & E-Commerce
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Hypertrophic & Keloid Scar Treatment Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Hypertrophic & Keloid Scar Treatment Market?
  3. What are the technology trends and regulatory frameworks in the Hypertrophic & Keloid Scar Treatment Market?
  4. What is the market share of the leading vendors in the Hypertrophic & Keloid Scar Treatment Market?
  5. Which modes and strategic moves are suitable for entering the Hypertrophic & Keloid Scar Treatment Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Hypertrophic & Keloid Scar Treatment Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of injuries causing hypertrophic & keloid scars
5.1.1.2. Rising awareness regarding the aesthetic surgery
5.1.2. Restraints
5.1.2.1. High cost associated with the laser treatments
5.1.3. Opportunities
5.1.3.1. Emergence of laser therapies and products for hypertrophic & keloid scar treatment
5.1.3.2. Introduction and availability of several topical creams
5.1.4. Challenges
5.1.4.1. Adverse effects and lack of knowledge regarding the hypertrophic & keloid scar treatment
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Hypertrophic & Keloid Scar Treatment Market, by Scar Type
6.1. Introduction
6.2. Hypertrophic Scar
6.3. Keloid Scar
7. Hypertrophic & Keloid Scar Treatment Market, by Product
7.1. Introduction
7.2. Injectables
7.3. Laser Products
7.4. Topical Products
8. Hypertrophic & Keloid Scar Treatment Market, by End-Use
8.1. Introduction
8.2. Clinics
8.3. Hospitals
8.4. Retail Pharmacies & E-Commerce
9. Americas Hypertrophic & Keloid Scar Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Hypertrophic & Keloid Scar Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Hypertrophic & Keloid Scar Treatment Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Alliance Pharma, PLC
13.1.2. Cynosure, Inc.
13.1.3. Honeydew Products
13.1.4. L'Oreal Group
13.1.5. Lumenis Be Ltd.
13.1.6. McKesson Medical-Surgical Inc.
13.1.7. Merz Pharma
13.1.8. Molnlycke Health Care AB
13.1.9. Newmedical Technology, Inc.
13.1.10. Pacific World Corporation
13.1.11. Perrigo Company PLC
13.1.12. Smith & Nephew PLC
13.1.13. Sonoma Pharmaceuticals, Inc.
13.1.14. Suneva Medical, Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, 2022 VS 2030
FIGURE 3. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET DYNAMICS
FIGURE 7. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2022 VS 2030 (%)
FIGURE 8. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 10. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
FIGURE 12. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 14. AMERICAS HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 16. UNITED STATES HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 22. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 6. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY HYPERTROPHIC SCAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY KELOID SCAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 9. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY LASER PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY TOPICAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 13. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY RETAIL PHARMACIES & E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 20. ARGENTINA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 23. BRAZIL HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 26. CANADA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 27. CANADA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. CANADA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 29. MEXICO HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 30. MEXICO HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. MEXICO HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 36. ASIA-PACIFIC HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. AUSTRALIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 43. CHINA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 44. CHINA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. CHINA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 46. INDIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 47. INDIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. INDIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 49. INDONESIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 52. JAPAN HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 53. JAPAN HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. JAPAN HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 55. MALAYSIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 58. PHILIPPINES HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 61. SINGAPORE HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 64. SOUTH KOREA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 67. TAIWAN HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 70. THAILAND HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 71. THAILAND HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. THAILAND HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 73. VIETNAM HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 80. DENMARK HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 81. DENMARK HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. DENMARK HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 83. EGYPT HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 84. EGYPT HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. EGYPT HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 86. FINLAND HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 87. FINLAND HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. FINLAND HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 89. FRANCE HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 90. FRANCE HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. FRANCE HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 92. GERMANY HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 93. GERMANY HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. GERMANY HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 95. ISRAEL HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 98. ITALY HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 99. ITALY HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. ITALY HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 101. NETHERLANDS HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 104. NIGERIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 107. NORWAY HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 108. NORWAY HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. NORWAY HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 110. POLAND HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 111. POLAND HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. POLAND HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 113. QATAR HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 114. QATAR HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. QATAR HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 125. SPAIN HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 126. SPAIN HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. SPAIN HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 131. SWITZERLAND HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 134. TURKEY HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 135. TURKEY HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. TURKEY HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 143. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 144. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
TABLE 145. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET LICENSE & PRICING

Companies Mentioned

  • Alliance Pharma, PLC
  • Cynosure, Inc.
  • Honeydew Products
  • L'Oreal Group
  • Lumenis Be Ltd.
  • McKesson Medical-Surgical Inc.
  • Merz Pharma
  • Molnlycke Health Care AB
  • Newmedical Technology, Inc.
  • Pacific World Corporation
  • Perrigo Company PLC
  • Smith & Nephew PLC
  • Sonoma Pharmaceuticals, Inc.
  • Suneva Medical, Inc.

Methodology

Loading
LOADING...

Table Information